Net Income for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current net income (TTM) is $20.74B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$20.74B
YoY change
+90.6%
5Y CAGR
+12.7%
Peak year (2023)
$35.15B
Cumulative net income
$373.86B
Net Income history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Net Income history table for Johnson & Johnson (JNJ) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $26.80B | +90.6% | ||
| 2024 | $14.07B | -60.0% | ||
| 2023 | $35.15B | +95.9% | ||
| 2022 | $17.94B | -14.1% | ||
| 2021 | $20.88B | +41.9% | ||
| 2020 | $14.71B | -2.7% | ||
| 2019 | $15.12B | -1.2% | ||
| 2018 | $15.30B | +1076.7% | ||
| 2017 | $1.30B | -92.1% | ||
| 2016 | $16.54B | +7.3% | ||
| 2015 | $15.41B | -5.6% | ||
| 2014 | $16.32B | +18.0% | ||
| 2013 | $13.83B | +27.4% | ||
| 2012 | $10.85B | +12.2% | ||
| 2011 | $9.67B | -27.5% | ||
| 2010 | $13.33B | +8.7% | ||
| 2009 | $12.27B | -5.3% | ||
| 2008 | $12.95B | +22.4% | ||
| 2007 | $10.58B | -4.3% | ||
| 2006 | $11.05B | +9.9% | ||
| 2005 | $10.06B | +23.0% | ||
| 2004 | $8.18B | +13.7% | ||
| 2003 | $7.20B | +9.1% | ||
| 2002 | $6.60B | +16.4% | ||
| 2001 | $5.67B | +14.4% | ||
| 2000 | $4.95B | +15.9% | ||
| 1999 | $4.27B | +42.3% | ||
| 1998 | $3.00B | -9.1% | ||
| 1997 | $3.30B | +14.4% | ||
| 1996 | $2.89B | +20.1% | ||
| 1995 | $2.40B | +19.8% | ||
| 1994 | $2.01B | +12.3% | ||
| 1993 | $1.79B | +73.5% | ||
| 1992 | $1.03B | -29.5% | ||
| 1991 | $1.46B | +27.8% | ||
| 1990 | $1.14B | +5.6% | ||
| 1989 | $1.08B | +11.1% | ||
| 1988 | $974.00M | +16.9% | ||
| 1987 | $833.00M | +152.8% | ||
| 1986 | $329.50M | -46.3% | ||
| 1985 | $613.70M | — |
Net Income values are taken from Johnson & Johnson's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual net income for Johnson & Johnson (JNJ) came in at $26.80B – surged 90.6% year-over-year.
Johnson & Johnson net income compound annual growth for the 2020–2025 (5 years) window is +12.7%, with the latest reading among the more recent periods of the dataset.
Johnson & Johnson net income declined from $35.15B in 2023 to $26.80B in 2025, a 23.8% drawdown.
2023 marks the peak net income at $35.15B, with the historical low of $329.50M recorded in 1986.
Within Healthcare, Johnson & Johnson (JNJ) ranks 2nd among 8 peers we track. The peer median for net income is $11.16B.
Johnson & Johnson Net Income by Year
Johnson & Johnson Net Income 2025: $26.80B
Johnson & Johnson net income in 2025 was $26.80B, surged 90.6% from 2024.
Johnson & Johnson Net Income 2024: $14.07B
Johnson & Johnson net income in 2024 was $14.07B, plunged 60.0% below 2023.
Johnson & Johnson Net Income 2023: $35.15B
Johnson & Johnson net income in 2023 was $35.15B, surged 95.9% from 2022. This figure represents the highest annual value in the available history.
Johnson & Johnson Net Income 2022: $17.94B
Johnson & Johnson net income in 2022 was $17.94B, declined 14.1% below 2021.
Johnson & Johnson Net Income 2021: $20.88B
Johnson & Johnson net income in 2021 was $20.88B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — Net Income
Companies in the same sector as Johnson & Johnson, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $6.74B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Johnson & Johnson's net income?
- Latest reported net income for Johnson & Johnson (JNJ) is $20.74B (period ending March 31, 2026).
How has Johnson & Johnson net income changed year-over-year?
- Johnson & Johnson (JNJ) net income changed +90.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson net income?
- Johnson & Johnson (JNJ) net income compound annual growth rate is +12.7% over the most recent 5 years available.
When did Johnson & Johnson net income hit its highest annual value?
- Johnson & Johnson net income reached its highest annual value of $35.15B in 2023.
What was Johnson & Johnson net income in 2024?
- Johnson & Johnson (JNJ) net income in 2024 was $14.07B.
What was Johnson & Johnson net income in 2025?
- Johnson & Johnson (JNJ) net income in 2025 was $26.80B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.